Anticholinergic drugs and risk of dementia: Time for action?-Reference-Cited by-同舟云学术

Anticholinergic drugs and risk of dementia: Time for action?

Published:2021-05 Issue:3 Volume:9 Page:
ISSN:2052-1707
Container-title:Pharmacology Research & Perspectives
language:en
Short-container-title:Pharmacol Res Perspect

Author:

Bell Brian¹^ORCID,Avery Anthony¹,Bishara Delia²,Coupland Carol¹,Ashcroft Darren³,Orrell Martin⁴

Affiliation:

1. Department of Primary Care University of Nottingham Nottingham UK

2. NIHR Maudsley Biomedical Research CentreSouth London and Maudsley NHS Trust London UK

3. School of Pharmacy and Pharmaceutical Sciences University of Manchester Manchester UK

4. Institute of Mental Health University of Nottingham Nottingham UK

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/prp2.793

Reference18 articles.

1. Greater Manchester Medicines Management Group.Management of overactive bladder in adults.2019. Available at:http://gmmmg.nhs.uk/docs/guidance/Management‐of‐OAB‐in‐adults‐v3‐0‐approved‐Aug‐2019.pdf

2. The Environment and Disease: Association or Causation?

3. Anticholinergic drugs and risk of dementia: case‐control study;Richardson K;BMJ,2018

4. Anticholinergic Drug Exposure and the Risk of Dementia

5. Preserving cognitive function for patients with overactive bladder: evidence for a differential effect with darifenacin

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vibegron shows high selectivity and potent agonist activity for β3-adrenoceptors, irrespective of receptor density;PLOS ONE;2023-09-01

2. Managing drugs with anticholinergic activity;Drug and Therapeutics Bulletin;2023-08-30

3. Clinical Pharmacy Congress 2022;Progress in Neurology and Psychiatry;2023-01

4. Anticholinergic action is rarely a good thing;Therapeutic Advances in Psychopharmacology;2023-01